MA26592A1 - Procede et medicament utilisant des composes cycliques, pour le traitement de la bronchopneumopathie chronique obstructive - Google Patents

Procede et medicament utilisant des composes cycliques, pour le traitement de la bronchopneumopathie chronique obstructive

Info

Publication number
MA26592A1
MA26592A1 MA25416A MA25416A MA26592A1 MA 26592 A1 MA26592 A1 MA 26592A1 MA 25416 A MA25416 A MA 25416A MA 25416 A MA25416 A MA 25416A MA 26592 A1 MA26592 A1 MA 26592A1
Authority
MA
Morocco
Prior art keywords
medicament
treatment
chronic obstructive
cyclic compounds
obstructive bronchopneumopathy
Prior art date
Application number
MA25416A
Other languages
English (en)
Inventor
B Christensen Siegfried Iv
Torphy Theodore
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MA26592A1 publication Critical patent/MA26592A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
MA25416A 1998-01-07 1999-01-04 Procede et medicament utilisant des composes cycliques, pour le traitement de la bronchopneumopathie chronique obstructive MA26592A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7071898P 1998-01-07 1998-01-07
US10690898P 1998-10-28 1998-10-28

Publications (1)

Publication Number Publication Date
MA26592A1 true MA26592A1 (fr) 2004-12-20

Family

ID=26751429

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25416A MA26592A1 (fr) 1998-01-07 1999-01-04 Procede et medicament utilisant des composes cycliques, pour le traitement de la bronchopneumopathie chronique obstructive

Country Status (34)

Country Link
US (1) US6369108B1 (fr)
EP (1) EP1051172B1 (fr)
JP (1) JP2003522095A (fr)
KR (1) KR100555824B1 (fr)
CN (1) CN1291891A (fr)
AP (1) AP2000001859A0 (fr)
AR (1) AR014411A1 (fr)
AT (1) ATE285234T1 (fr)
AU (1) AU752497B2 (fr)
BG (1) BG104654A (fr)
BR (1) BR9906803A (fr)
CA (1) CA2317720A1 (fr)
DE (1) DE69922786T2 (fr)
DZ (1) DZ2703A1 (fr)
EA (1) EA006382B1 (fr)
EG (1) EG23945A (fr)
ES (1) ES2234234T3 (fr)
HK (1) HK1033551A1 (fr)
HU (1) HUP0100888A3 (fr)
ID (1) ID26164A (fr)
IL (1) IL137104A0 (fr)
MA (1) MA26592A1 (fr)
MY (1) MY133014A (fr)
NO (1) NO20003481L (fr)
NZ (1) NZ505521A (fr)
OA (1) OA11443A (fr)
PE (1) PE20000231A1 (fr)
PL (1) PL341667A1 (fr)
PT (1) PT1051172E (fr)
SI (1) SI1051172T1 (fr)
SK (1) SK285149B6 (fr)
TR (1) TR200001819T2 (fr)
UY (1) UY25338A1 (fr)
WO (1) WO1999034798A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DZ3019A1 (fr) 1999-03-01 2005-05-20 Smithkline Beecham Corp Utilisation d'un inhibiteur de pde4 dans la préparation d'un médicament contre la copd.
AR024076A1 (es) * 1999-05-25 2002-09-04 Smithkline Beecham Corp Sales de cis-[4-ciano-4-(3-ciclopentiloxi-4-metoxifenil) ciclohexan-1-carboxilato]
MXPA02001471A (es) * 1999-08-10 2002-07-02 Smithkline Beecham Corp 4,4-diaril ciclohexanos 1,4-substituidos.
EP1237851A4 (fr) * 1999-12-15 2004-06-23 Smithkline Beecham SELS D'ACIDE CARBOXYLIQUE i Cis /i -4-CYANO-4- 3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]CYCLOHEXANE-1
EP2258689A1 (fr) 2000-03-16 2010-12-08 Biolipox AB Inhibiteurs benzyles de PDE4
DE10245153A1 (de) * 2002-09-27 2004-04-15 Infineon Technologies Ag Integrierter Feldeffekttransistor mit zwei Steuerbereichen, Verwendung dieses Feldeffekttranistors und Herstellungsverfahren
EP1893583B1 (fr) 2005-05-31 2012-04-04 Pfizer Inc. Derives d'aryloxy-n-bicyclomethyl acetamide substitues en tant qu'antagonistes de vr1
MX2009012644A (es) * 2007-06-05 2009-12-10 Sanofi Aventis Derivados de di(hetero)arilciclohexano, su preparacion, su uso y composiciones farmaceuticas que los comprenden.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3199380B2 (ja) * 1992-04-02 2001-08-20 スミスクライン・ビーチャム・コーポレイション 化合物
US5552438A (en) * 1992-04-02 1996-09-03 Smithkline Beecham Corporation Compounds useful for treating allergic and inflammatory diseases
GB9525262D0 (en) * 1995-12-11 1996-02-07 Bayer Ag Heterocyclylcarbonyl substituted benzofuranyl-ureas

Also Published As

Publication number Publication date
KR100555824B1 (ko) 2006-03-03
CA2317720A1 (fr) 1999-07-15
US6369108B1 (en) 2002-04-09
AR014411A1 (es) 2001-02-28
SK285149B6 (sk) 2006-07-07
HUP0100888A3 (en) 2003-07-28
BR9906803A (pt) 2002-05-28
JP2003522095A (ja) 2003-07-22
HUP0100888A2 (hu) 2001-08-28
WO1999034798A1 (fr) 1999-07-15
ES2234234T3 (es) 2005-06-16
EG23945A (en) 2008-01-22
OA11443A (en) 2004-04-28
EA006382B1 (ru) 2005-12-29
EP1051172A2 (fr) 2000-11-15
DE69922786T2 (de) 2005-06-23
NO20003481D0 (no) 2000-07-06
MY133014A (en) 2007-10-31
PT1051172E (pt) 2005-03-31
SI1051172T1 (en) 2005-06-30
ATE285234T1 (de) 2005-01-15
SK10232000A3 (sk) 2001-01-18
AP2000001859A0 (en) 2000-09-30
DZ2703A1 (fr) 2003-09-01
CN1291891A (zh) 2001-04-18
AU752497B2 (en) 2002-09-19
HK1033551A1 (en) 2001-09-07
PE20000231A1 (es) 2000-03-24
KR20010033909A (ko) 2001-04-25
BG104654A (en) 2001-04-30
ID26164A (id) 2000-11-30
EA200000740A1 (ru) 2001-02-26
EP1051172A4 (fr) 2002-08-14
NZ505521A (en) 2004-02-27
AU2106099A (en) 1999-07-26
EP1051172B1 (fr) 2004-12-22
NO20003481L (no) 2000-08-25
UY25338A1 (es) 2001-08-27
DE69922786D1 (de) 2005-01-27
PL341667A1 (en) 2001-04-23
TR200001819T2 (tr) 2000-11-21
IL137104A0 (en) 2001-06-14

Similar Documents

Publication Publication Date Title
ATE320257T1 (de) (s,s)-reboxetine zur behandlung chronischer schmerzen
IS6560A (is) Lyfjasamsetning fyrir meðhöndlun á bráðum, þrálátum sársauka og/eða taugakerfissársauka og mígreni
PT867184E (pt) Utilizacao de tiagabina para o tratamento de desordens do sono
EP1027095A4 (fr) Appareil et methode de traitement de nephropathie aigue et chronique par ultrafiltration passive de plasma en continu
DE69535686D1 (de) Vorrichtung zur synchronen Behandlung von obstruktiver Schlafapnoe
DE60042984D1 (de) Arzneitmittel zur Behandlung von Duchenne-Muskeldystrophie
HUP0103856A2 (hu) Gyógyszerkészítmény akut rendellenességek kezelésére
MA26435A1 (fr) Derives de benzylamine amido-substitues, leurs derives precurseurs de medicaments, leur procede de preparation, compositions pharmaceutiques les contenant et methode de traitement les utilisant.
MA25223A1 (fr) Procede pour la preparation de 4-carboxy-amino-2-substitue-1,2,3,4 tetrahydroquinoleine
EE200200571A (et) Hüdroksüfenüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks
MA26779A1 (fr) Derives de 1-arenesulfonyl-2-aryl-pyrrolidine et de piperidine pour le traitement de troubles du systeme nerveux central.
DZ3014A1 (fr) Médicaments pour le traitement de l'hypertension.
DK0846173T3 (da) Anvendelse af et anti-interleukin-9-antistof til fremstilling af et lægemiddel til behandling af astma
DZ3393A1 (fr) Procede de detection de composes apropries pour le traitement et/ou la prophylaxie de l'obesite
MA26592A1 (fr) Procede et medicament utilisant des composes cycliques, pour le traitement de la bronchopneumopathie chronique obstructive
NO973589D0 (no) Medikament for behandlingen av besettende kompulsivproblemer, sövnapne, seksuelle funksjonsforstyrrelser, emesi og reisesyke
HK1051692A1 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain.
EE200200511A (et) Hüdroksüfenüülpiperasinüülmetüülbensamiidi derivaadid valu raviks
NO20020784L (no) Medikament for behandling av brudd
MA25852A1 (fr) Methode pour le traitement de l'inflammation.
FR2800614B1 (fr) Composition pour le traitement des infections des voies respiratoires
FR2816611B1 (fr) Procede de traitement d'eaux usees
WO2000076457A3 (fr) Antagonistes du recepteur il-8
NO996060D0 (no) Pusteapparat for behandling av soevnapne
NO20006383L (no) Fremgangsmåte for behandling